| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 523.68B | 541.88B | 516.13B | 506.87B | 527.26B | 501.87B |
| Gross Profit | 78.33B | 83.03B | 76.97B | 74.40B | 78.28B | 72.74B |
| EBITDA | 16.14B | 17.23B | 17.27B | 14.97B | 20.91B | 20.15B |
| Net Income | 9.03B | 9.33B | 7.84B | 6.49B | 12.53B | 12.02B |
Balance Sheet | ||||||
| Total Assets | 282.00B | 351.99B | 292.26B | 294.97B | 288.89B | 282.65B |
| Cash, Cash Equivalents and Short-Term Investments | 66.35B | 109.13B | 75.03B | 89.09B | 82.14B | 82.40B |
| Total Debt | 13.00B | 58.59B | 13.10B | 13.62B | 14.16B | 14.68B |
| Total Liabilities | 157.05B | 211.83B | 164.33B | 162.35B | 165.13B | 169.28B |
| Stockholders Equity | 123.61B | 138.42B | 126.59B | 131.51B | 122.93B | 112.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 799.00M | 3.69B | 9.05B | 4.56B | 2.98B |
| Operating Cash Flow | 0.00 | 6.07B | 8.93B | 11.45B | 7.91B | 7.16B |
| Investing Cash Flow | 0.00 | -12.02B | -11.88B | -1.46B | -3.70B | -3.14B |
| Financing Cash Flow | 0.00 | 38.79B | -10.52B | -4.54B | -4.92B | 1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥103.87B | 136.93 | 5.02% | 3.23% | -30.60% | -84.58% | |
79 Outperform | ¥278.12B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
79 Outperform | ¥127.32B | 9.64 | ― | 3.24% | 8.95% | 18.54% | |
73 Outperform | ¥56.50B | 13.82 | ― | 2.54% | 3.47% | -12.26% | |
67 Neutral | ¥98.11B | 22.58 | ― | 4.45% | 8.29% | 117.44% | |
65 Neutral | ¥153.17B | 13.13 | ― | 3.47% | 4.99% | 20.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |